John Cremin

John Cremin is a Senior Scientist at Novoloop, bringing over 17 years of experience in the pharmaceutical industry, specializing in drug metabolism and pharmacokinetics. Previously, John held positions as a Senior Scientist at Integrated Analytical Solutions, Intertek Pharmaceutical Services, and Achaogen, where they managed and developed GLP-compliant bioanalytical methods for small molecules, proteins, and peptides. They have also served as an Associate Director at Signature Therapeutics, leading critical assays that significantly advanced drug discovery efforts. John has a strong academic background with multiple post-doctoral fellowships and advanced degrees in Animal Sciences, Environmental Toxicology, and Nutrition Sciences from prestigious institutions.